Skip to main content

Table 2 Baseline characteristics of PD patients

From: Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients

PD patients

ESA ≤4,000 (units/week)

ESA >4,000 (units/week)

 

Hb ≥11 (g/dl)

Hb <11 (g/dl)

Hb ≥11 (g/dl)

Hb <11 (g/dl)

Number

204

91

113

53

Age (years)

52.0 (14.7)

50.6 (15.1)

57.9 (15.5)

49.8 (16.1)

Sex (%) men

64.2

65.9

73.2

60.4

Weight (kg)

73.1 (12.8)

73.5 (14.3)

77.8 (13.7)

77.9 (16.8)

ESA dose (units/week)

4,000 (2,000-4,000)

4,000 (2,000-4,000)

8,000 (6,000-8,000)

9,000 (8,000-12,000)

ERI (units/week/kg/Hb)

3.4 (1.4)

4.5 (1.8)

9.0 (4.4)

14.9 (8.5)

Primary kidney disease (%)

    

- Diabetes mellitus

10.8

19.8

17.0

13.2

- Glomerulonephritis

18.1

17.6

17.9

17.0

- Renal vascular disease

7.8

8.8

21.4

13.2

- Other

63.2

53.8

43.8

56.6

Comorbidity (%)

    

- Diabetes mellitus

13.2

19.8

23.9

15.1

- Malignancy

5.4

2.2

8.8

5.7

- Cardiovascular disease

19.6

17.6

31.9

20.8

Weekly Kt/V urea (Watson)

2.3 (0.6)

2.1 (0.4)

2.3 (0.6)

2.1 (0.5)

rGFR (ml/min/1.73 m2)

3.7 (2.0-5.6)

2.7 (1.0-3.8)

3.1 (1.2-5.1)

1.3 (0.5-3.3)

Nutritional status (SGA) (%)

    

- Severely malnourished

0.6

0.0

0.0

0.0

- Mild-moderate

13.4

24.7

15.6

22.7

- Well-nourished

86.0

75.3

84.4

77.3

Laboratory values

    

- Hemoglobin (g/dl)

12.4 (11.8-13.3)

9.7 (10.3-10.8)

12.4 (11.7-13.2)

10.0 (9.5-10.8)

- Albumin (g/l)

37.4 (4.7)

35.4 (6.0)

36.0 (5.5)

34.0 (6.1)

- Ferritin (μg/l)

138 (63–232)

186 (81–294)

99 (51–180)

218 (114–479)

- PTH (pmol/l)

11.6 (4.6-23.8)

10.8 (3.6-31.3)

12.1 (4.3-28.9)

16.4 (3.5-25.0)

- CRP (mg/l)

4.0 (3.0-8.0)

4.0 (3.0-14.0)

9.5 (5.0-16.3)

7.0 (3.0-11.0)

  1. Values are presented as mean (SD), median (IQR) or percentage.